Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Biogen Inc.    BIIB

BIOGEN INC.

(BIIB)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsAnalyst Recommendations
Most relevant news about BIOGEN INC.
10/22BIOGEN : Reversing Itself, to Seek FDA OK for Alzheimer's Drug -- 5th Update
DJ
10/22BIOGEN : Reversing Itself, to Seek FDA OK for Alzheimer's Drug -- 4th Update
DJ
10/22Biogen soars on Wall Street; McDonald's, Howard Hughes fall
AQ
10/22BIOGEN : Quarterly report which provides a continuing view of a company's financ..
PU
10/22BIOGEN : reanalyzes studies, presses ahead on Alzheimer's drug
AQ
10/22BIOGEN : Reversing Itself, to Seek FDA OK for Alzheimer's Drug -- 3rd Update
DJ
10/22Biogen Up Over 31%, On Pace for Record Percent Increase -- Data Talk
DJ
10/22BIOGEN : Reversing Itself, to Seek FDA OK for Alzheimer's Drug -- 2nd Update
DJ
10/22BIOGEN : Company says it will seek approval of Alzheimer's drug
AQ
10/22BIOGEN : Reversing Itself, to Seek FDA OK for Alzheimer's Drug -- Update
DJ
10/22BIOGEN : Up 40% Premarket on Revived Alzheimer's Drug
DJ
10/22BIOGEN : 3Q Profit, Revenue Rise
DJ
10/22BIOGEN : Q3 2019 Biogen Earnings presentation
PU
10/22BIOGEN : Reports Q3 2019 Revenues of $3.6 Billion
PU
10/22BIOGEN : Aducanumab Update Presentation
PU
More most relevant news
All news about BIOGEN INC.
02:48aNovartis Lauds Launch of Pricey Gene Therapy -- WSJ
DJ
01:45aBiogen, Eisai revive plans for Alzheimer's drug, surprising market
RE
10/22Wall Street slips after rejection of Brexit timetable
RE
10/22BIOGEN : Reversing Itself, to Seek FDA OK for Alzheimer's Drug -- 5th Update
DJ
10/22BIOGEN : Reversing Itself, to Seek FDA OK for Alzheimer's Drug -- 4th Update
DJ
10/22MARKET SNAPSHOT: Stock Market Ends Lower As New Social-media Bill And Brexit ..
DJ
10/22Biogen soars on Wall Street; McDonald's, Howard Hughes fall
AQ
10/22BIOGEN : Quarterly report which provides a continuing view of a company's financ..
PU
10/22BIOGEN : Management's Discussion and Analysis of Financial Condition and Results..
AQ
10/22BIOGEN : reanalyzes studies, presses ahead on Alzheimer's drug
AQ
More news
News in other languages on BIOGEN INC.
05:23aBOURSES ASIATIQUES : Tokyo optimiste, places chinoises dans le doute
10/22Tokyo ouvre sur une note hésitante
10/22Biogen veut faire approuver en 2020 un traitement contre la maladie d'Alzheim..
10/22Kehrtwende bei Alzheimer-Mittel - Biogen plant US-Zulassung
10/22Wall Street ouvre en légère hausse en pleine saison des résultats
10/22Biogen will Alzheimer-Mittel zulassen - Gewinnsprung - Aktie vorbörslich gefr..
10/22WALL STREET STOCK EXCHANGE : Les valeurs à suivre à Wall Street
10/22BIOGEN : vers une demande d'approbation dans Alzheimer
10/22WALL STREET STOCK EXCHANGE : USA-Les valeurs à suivre à Wall Street (actualisé)
10/22Pharmariese Novartis legt die Latte zum dritten Mal höher
Press releases
10/22Biogen soars on Wall Street; McDonald's, Howard Hughes fall
AQ
10/22BIOGEN : Quarterly report which provides a continuing view of a company's financ..
PU
10/22BIOGEN : Management's Discussion and Analysis of Financial Condition and Results..
AQ
10/22BIOGEN : reanalyzes studies, presses ahead on Alzheimer's drug
AQ
10/22BIOGEN : Company says it will seek approval of Alzheimer's drug
AQ
More press releases
Sector news : Biopharmaceuticals
03:11pTeva's proposed opioid settlement could cost drugmaker pennies on the dollar
RE
02:26pELI LILLY AND : Medicare Funding Weighs on Eli Lilly's Revenue -- Update
DJ
01:10pDR REDDY LABORATORIES : . Reddy's Recalls Ranitidine Medications in U.S.
DJ
10:40aELI LILLY AND : Shares Decline After Co. Reported Revenue Miss
DJ
09:39aALLERGAN : Form 8.3 - Allergan Plc
DJ
More sector news : Biopharmaceuticals
Upcoming event on BIOGEN INC.